Skip to content

Assessing the Clinical Efficacy of Bentonite Clay Gel on Bone Regeneration in the Treatment of Intra-bony Defects: A Clinico-radiograph Study

Assessing the Clinical Efficacy of Bentonite Clay Gel on Bone Regeneration in the Treatment of Intra-bony Defects: A Clinico-radiograph Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06439264
Enrollment
24
Registered
2024-06-03
Start date
2023-05-03
Completion date
2024-05-31
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Regeneration

Brief summary

The aim of this study is to evaluate osseous regeneration efficacy of bentonite gel with hydroxyapatite in comparison with hydroxyapatite incase of intrabony defects The test group includes patients with intrabony defects where flap surgery is will be performed and bentonite clay gel with HA will be placed and in control group only HA is placed.

Detailed description

Experimental: Main treatment group bentonite with hydroxyaatite is added into the defect site. Comparator: In patients allocated to control group,only hydroxyapatite is added.

Interventions

OTHERbentonite clay gel with hydroxyapatite

bentonite clay gel presents great potential for bone healing and it leads to the formation of interconnected microporous structure, which can promote native cell infiltration, proliferation,

Sponsors

Dr R Viswa Chandra
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Systemically healthy male and female patients of age \>18 years 2. two-walled or three-walled intrabony defects and 3. probing pocket depths (PPD) of ≥ 5mm.

Exclusion criteria

1. Medically compromised patients, 2. patients \<18 years of age, 3. pregnant women, 4. heavy smokers, and 5. patients who underwent radiotherapy or chemotherapy are excluded.

Design outcomes

Primary

MeasureTime frameDescription
RVGbaseline , 3months,6months1\. Radiovisiography will be used to assess bone regeneration achieved post operatively after 3 months and 6 months.
probing depthbaseline , 3months,6months2\. Assessment of probing depth using probe at baseline and postoperatively at 3 and 6 months
clinical attachment levelbaseline , 3months,6monthsAssessment of clinical attachment level using probe at baseline and post operatively at 3 and 6 months.

Secondary

MeasureTime frameDescription
1. Assessment of plaque - according to Turesky modification of Quigley and Hein Plaque Index, 1970. 2. Assessment of Gingivitis - according to Loe H and Silness P, 1963.baseline ,3months,6months1. Assessment of plaque - according to Turesky modification of Quigley and Hein Plaque Index, 1970. 2. Assessment of Gingivitis - according to Loe H and Silness P, 1963.

Countries

India

Contacts

Primary ContactDr.viswa chandra MDS
viswachandra@hotmail.com9912161007

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026